| MeSH term | MeSH ID | Detail |
|---|---|---|
| Respirovirus Infections | D010253 | 3 associated lipids |
| Osteitis Deformans | D010001 | 3 associated lipids |
| Measles | D008457 | 3 associated lipids |
| Malocclusion | D008310 | 3 associated lipids |
| Hyperparathyroidism | D006961 | 3 associated lipids |
| Glucose Metabolism Disorders | D044882 | 3 associated lipids |
| Cryptosporidiosis | D003457 | 3 associated lipids |
| Carcinoma, Papillary | D002291 | 3 associated lipids |
| Myositis, Inclusion Body | D018979 | 3 associated lipids |
| Mitral Valve Stenosis | D008946 | 3 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Gurban CV and Mederle O | The OPG/RANKL system and zinc ions are promoters of bone remodeling by osteoblast proliferation in postmenopausal osteoporosis. | 2011 | Rom J Morphol Embryol | pmid:22119834 |
| Ostrowska Z et al. | Circadian concentrations of free testosterone, selected markers of bone metabolism, osteoprotegerin and its ligand sRANKL in obese postmenopausal women. | 2011 | Postepy Hig Med Dosw (Online) | pmid:22100799 |
| Kurabayashi M | [Bone and calcium update; diagnosis and therapy of bone metabolism disease update. Calcification of atherosclerotic plaques: mechanism and clinical significance]. | 2011 | Clin Calcium | pmid:22133823 |
| Sood SK et al. | Osteoprotegerin (OPG) and related proteins (RANK, RANKL and TRAIL) in thyroid disease. | 2011 | World J Surg | pmid:21748518 |
| Stein SH and Tipton DA | Vitamin D and its impact on oral health--an update. | 2011 | J Tenn Dent Assoc | pmid:21748977 |
| Xie H et al. | Omentin-1 attenuates arterial calcification and bone loss in osteoprotegerin-deficient mice by inhibition of RANKL expression. | 2011 | Cardiovasc. Res. | pmid:21750093 |
| Wang Y et al. | Alendronate (ALN) combined with osteoprotegerin (OPG) significantly improves mechanical properties of long bone than the single use of ALN or OPG in the ovariectomized rats. | 2011 | J Orthop Surg Res | pmid:21752290 |
| Plasilova M et al. | Discordant gene expression signatures and related phenotypic differences in lamin A- and A/C-related Hutchinson-Gilford progeria syndrome (HGPS). | 2011 | PLoS ONE | pmid:21738662 |
| Ren G et al. | Simultaneous administration of fluoride and selenite regulates proliferation and apoptosis in murine osteoblast-like MC3T3-E1 cells by altering osteoprotegerin. | 2011 | Biol Trace Elem Res | pmid:21739163 |
| Sylvester FA et al. | Fecal osteoprotegerin may guide the introduction of second-line therapy in hospitalized children with ulcerative colitis. | 2011 | Inflamm. Bowel Dis. | pmid:21744427 |
| Tipton DA et al. | Effect of bisphosphonates on human gingival fibroblast production of mediators of osteoclastogenesis: RANKL, osteoprotegerin and interleukin-6. | 2011 | J. Periodont. Res. | pmid:20701670 |
| Bellido M et al. | Improving subchondral bone integrity reduces progression of cartilage damage in experimental osteoarthritis preceded by osteoporosis. | 2011 | Osteoarthr. Cartil. | pmid:21820069 |
| Lawrie A et al. | Paigen diet-fed apolipoprotein E knockout mice develop severe pulmonary hypertension in an interleukin-1-dependent manner. | 2011 | Am. J. Pathol. | pmid:21835155 |
| Poulsen MK et al. | Plasma osteoprotegerin is related to carotid and peripheral arterial disease, but not to myocardial ischemia in type 2 diabetes mellitus. | 2011 | Cardiovasc Diabetol | pmid:21838881 |
| Markatseli AE et al. | Association of the A1330V and V667M polymorphisms of LRP5 with bone mineral density in Greek peri- and postmenopausal women. | 2011 | Maturitas | pmid:21840657 |
| Kauther MD et al. | Calcitonin substitution in calcitonin deficiency reduces particle-induced osteolysis. | 2011 | BMC Musculoskelet Disord | pmid:21843355 |
| Sudrová M et al. | Influence of long-term thromboprophylaxis with low-molecular-weight heparin (enoxaparin) on changes of bone metabolism markers in pregnant women. | 2011 | Clin. Appl. Thromb. Hemost. | pmid:20682598 |
| Mamalis AA et al. | Chemical modification of an implant surface increases osteogenesis and simultaneously reduces osteoclastogenesis: an in vitro study. | 2011 | Clin Oral Implants Res | pmid:21070383 |
| Vitoratos N et al. | Maternal circulating osteoprotegerin and soluble RANKL in pre-eclamptic women. | 2011 | Eur. J. Obstet. Gynecol. Reprod. Biol. | pmid:21074311 |
| Belibasakis GN et al. | Oral biofilm challenge regulates the RANKL-OPG system in periodontal ligament and dental pulp cells. | 2011 | Microb. Pathog. | pmid:21075196 |
| Wattanaroonwong N et al. | Oestrogen inhibits osteoclast formation induced by periodontal ligament fibroblasts. | 2011 | Arch. Oral Biol. | pmid:21035111 |
| Kaneko K and Kawai S | [Mechanisms and therapeutics of glucocorticoid-induced osteoporosis]. | 2011 | Nihon Rinsho Meneki Gakkai Kaishi | pmid:21720102 |
| Zhang Y et al. | Study of the mechanisms by which Sambucus williamsii HANCE extract exert protective effects against ovariectomy-induced osteoporosis in vivo. | 2011 | Osteoporos Int | pmid:20414641 |
| Hie M and Tsukamoto I | Vitamin C-deficiency stimulates osteoclastogenesis with an increase in RANK expression. | 2011 | J. Nutr. Biochem. | pmid:20444587 |
| Nich C et al. | Oestrogen deficiency modulates particle-induced osteolysis. | 2011 | Arthritis Res. Ther. | pmid:21696618 |
| Belibasakis GN et al. | Porphyromonas gingivalis induces RANKL in T-cells. | 2011 | Inflammation | pmid:20446027 |
| Clézardin P | [The role of RANK/RANKL/osteoprotegerin (OPG) triad in cancer-induced bone diseases: physiopathology and clinical implications]. | 2011 | Bull Cancer | pmid:21700551 |
| Celczyńska Bajew L et al. | The effects of osteoprotegerin (OPG) gene polymorphism in patients with ischaemic heart disease on the morphology of coronary arteries and bone mineral density. | 2011 | Kardiol Pol | pmid:21678294 |
| Dzida G | [Decalcified bones, calcified heart?]. | 2011 | Kardiol Pol | pmid:21678295 |
| Yang Q et al. | Plasma osteoprotegerin levels and long-term prognosis in patients with intermediate coronary artery lesions. | 2011 | Clin Cardiol | pmid:21678453 |
| Toffoli B et al. | Osteoprotegerin promotes vascular fibrosis via a TGF-β1 autocrine loop. | 2011 | Atherosclerosis | pmid:21679949 |
| de Moraes M et al. | Comparative immunohistochemical expression of RANK, RANKL and OPG in radicular and dentigerous cysts. | 2011 | Arch. Oral Biol. | pmid:21683340 |
| Ndip A et al. | The RANKL/RANK/OPG signaling pathway mediates medial arterial calcification in diabetic Charcot neuroarthropathy. | 2011 | Diabetes | pmid:21659498 |
| Davenport C et al. | Identifying coronary artery disease in men with type 2 diabetes: osteoprotegerin, pulse wave velocity, and other biomarkers of cardiovascular risk. | 2011 | J. Hypertens. | pmid:21970938 |
| Miyamoto K et al. | Osteoclasts are dispensable for hematopoietic stem cell maintenance and mobilization. | 2011 | J. Exp. Med. | pmid:22006978 |
| Quemerais-Durieu MA et al. | [Therapeutic innovation in osteoporosis (antisclerostin antibody and denosumab)]. | 2011 | Ann. Endocrinol. (Paris) | pmid:22008272 |
| Koo HM et al. | Elevated osteoprotegerin is associated with inflammation, malnutrition and new onset cardiovascular events in peritoneal dialysis patients. | 2011 | Atherosclerosis | pmid:22015178 |
| Cao H et al. | Dysregulated atrial gene expression of osteoprotegerin/receptor activator of nuclear factor-κB (RANK)/RANK ligand axis in the development and progression of atrial fibrillation. | 2011 | Circ. J. | pmid:22001292 |
| Scialla JJ et al. | Correlates of osteoprotegerin and association with aortic pulse wave velocity in patients with chronic kidney disease. | 2011 | Clin J Am Soc Nephrol | pmid:21940840 |
| Sfiridaki K et al. | Angiogenesis-related cytokines, RANKL, and osteoprotegerin in multiple myeloma patients in relation to clinical features and response to treatment. | 2011 | Mediators Inflamm. | pmid:21941412 |
| Bao L et al. | Anthraquinone compounds from Morinda officinalis inhibit osteoclastic bone resorption in vitro. | 2011 | Chem. Biol. Interact. | pmid:21945525 |
| Cianciolo G et al. | Effects of unfractioned heparin and low-molecular-weight heparin on osteoprotegerin and RANKL plasma levels in haemodialysis patients. | 2011 | Nephrol. Dial. Transplant. | pmid:20659908 |
| Chin A et al. | Effects of medicinal herb salvia miltiorrhiza on osteoblastic cells in vitro. | 2011 | J. Orthop. Res. | pmid:21319217 |
| Mencej-BedraÄ S et al. | TNFRSF11B gene polymorphisms 1181G > C and 245T > G as well as haplotype CT influence bone mineral density in postmenopausal women. | 2011 | Maturitas | pmid:21411255 |
| Lee JC et al. | Role of RANK-RANKL-OPG axis in cranial suture homeostasis. | 2011 | J Craniofac Surg | pmid:21415639 |
| Goto H et al. | Human bone marrow adipocytes support dexamethasone-induced osteoclast differentiation and function through RANKL expression. | 2011 | Biomed. Res. | pmid:21383509 |
| Belibasakis GN et al. | The RANKL-OPG system is differentially regulated by supragingival and subgingival biofilm supernatants. | 2011 | Cytokine | pmid:21474331 |
| Riksen EA et al. | Human osteoblastic cells discriminate between 20-kDa amelogenin isoforms. | 2011 | Eur. J. Oral Sci. | pmid:22243268 |
| Yang Z et al. | [Effects of negative pressure on osteogenesis in human bone marrow-derived stroma cells cultured in vitro]. | 2011 | Zhongguo Gu Shang | pmid:22276514 |
| Hall J et al. | A controlled clinical exploratory study on genetic markers for peri-implantitis. | 2011 | Eur J Oral Implantol | pmid:22282733 |
| Moldenhauer A et al. | Interleukin 32 promotes hematopoietic progenitor expansion and attenuates bone marrow cytotoxicity. | 2011 | Eur. J. Immunol. | pmid:21469100 |
| Kim H et al. | Association between Wnt signaling pathway gene polymorphisms and bone response to hormone therapy in postmenopausal Korean women. | 2011 | Menopause | pmid:21471826 |
| Mulcahy LE et al. | RANKL and OPG activity is regulated by injury size in networks of osteocyte-like cells. | 2011 | Bone | pmid:20854946 |
| Aspenberg P et al. | Targeting RANKL for reduction of bone loss around unstable implants: OPG-Fc compared to alendronate in a model for mechanically induced loosening. | 2011 | Bone | pmid:20858557 |
| Kurnatowska I et al. | Serum osteoprotegerin is a predictor of progression of atherosclerosis and coronary calcification in hemodialysis patients. | 2011 | Nephron Clin Pract | pmid:20861651 |
| de Souza Faloni AP et al. | Jaw and long bone marrows have a different osteoclastogenic potential. | 2011 | Calcif. Tissue Int. | pmid:20862464 |
| Bostanci N et al. | Effect of periodontal treatment on receptor activator of NF-κB ligand and osteoprotegerin levels and relative ratio in gingival crevicular fluid. | 2011 | J. Clin. Periodontol. | pmid:21261673 |
| Andersen GØ et al. | Elevated serum osteoprotegerin levels measured early after acute ST-elevation myocardial infarction predict final infarct size. | 2011 | Heart | pmid:21270073 |
| Tsukamoto S et al. | Clinical significance of osteoprotegerin expression in human colorectal cancer. | 2011 | Clin. Cancer Res. | pmid:21270110 |
| Monnouchi S et al. | The roles of angiotensin II in stretched periodontal ligament cells. | 2011 | J. Dent. Res. | pmid:21270461 |
| Chang YH et al. | Serum osteoprotegerin and tumor necrosis factor related apoptosis inducing-ligand (TRAIL) are elevated in type 2 diabetic patients with albuminuria and serum osteoprotegerin is independently associated with the severity of diabetic nephropathy. | 2011 | Metab. Clin. Exp. | pmid:21251686 |
| Benslimane-Ahmim Z et al. | Osteoprotegerin, a new actor in vasculogenesis, stimulates endothelial colony-forming cells properties. | 2011 | J. Thromb. Haemost. | pmid:21255246 |
| Bai P et al. | Disturbance of the OPG/RANK/RANKL pathway and systemic inflammation in COPD patients with emphysema and osteoporosis. | 2011 | Respir. Res. | pmid:22176920 |
| Piedra M et al. | "Single nucleotide polymorphisms of the OPG/RANKL system genes in primary hyperparathyroidism and their relationship with bone mineral density". | 2011 | BMC Med. Genet. | pmid:22185226 |
| Kawaguchi H | [Approach for therapeutic targets of osteoarthritis]. | 2011 | Nippon Yakurigaku Zasshi | pmid:21747205 |
| Hou WW et al. | Involvement of Wnt activation in the micromechanical vibration-enhanced osteogenic response of osteoblasts. | 2011 | J Orthop Sci | pmid:21833614 |
| Nahidi L et al. | Osteoprotegerin in pediatric Crohn's disease and the effects of exclusive enteral nutrition. | 2011 | Inflamm. Bowel Dis. | pmid:20848544 |
| Hashiguchi D et al. | Mineral trioxide aggregate solution inhibits osteoclast differentiation through the maintenance of osteoprotegerin expression in osteoblasts. | 2011 | J Biomed Mater Res A | pmid:21171155 |
| Li JY et al. | Ovariectomy disregulates osteoblast and osteoclast formation through the T-cell receptor CD40 ligand. | 2011 | Proc. Natl. Acad. Sci. U.S.A. | pmid:21187391 |
| Watkins M et al. | Osteoblast connexin43 modulates skeletal architecture by regulating both arms of bone remodeling. | 2011 | Mol. Biol. Cell | pmid:21346198 |
| Confavreux CB | Bone: from a reservoir of minerals to a regulator of energy metabolism. | 2011 | Kidney Int. Suppl. | pmid:21346725 |
| Lau CP et al. | Pamidronate, farnesyl transferase, and geranylgeranyl transferase-I inhibitors affects cell proliferation, apoptosis, and OPG/RANKL mRNA expression in stromal cells of giant cell tumor of bone. | 2011 | J. Orthop. Res. | pmid:20886653 |
| Kuczkowski J et al. | Expression of the receptor activator for nuclear factor-κB ligand and osteoprotegerin in chronic otitis media. | 2010 Nov-Dec | Am J Otolaryngol | pmid:20015790 |
| Kuczkowski J et al. | [Molecular control of bone resorption in chronic otitis media with cholesteatoma]. | 2010 Jul-Aug | Otolaryngol Pol | pmid:20873097 |
| Reyes-GarcÃa R et al. | Effects of alendronate treatment on serum levels of osteoprotegerin and total receptor activator of nuclear factor kappaB in women with postmenopausal osteoporosis. | 2010 Jan-Feb | Menopause | pmid:19574937 |
| Mori K et al. | Effects of pravastatin on serum osteoprotegerin levels in patients with hypercholesterolemia and type 2 diabetes. | 2010 Feb-Mar | Angiology | pmid:19147525 |
| Nuntapornsak A et al. | Changes in the mRNA expression of osteoblast-related genes in response to beta(3)-adrenergic agonist in UMR106 cells. | 2010 | Cell Biochem. Funct. | pmid:19827007 |
| Lee JH et al. | Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal. | 2010 | Mol. Pharmacol. | pmid:19828731 |
| Bae YJ and Kim MH | Calcium and Magnesium Supplementation Improves Serum OPG/RANKL in Calcium-Deficient Ovariectomized Rats. | 2010 | Calcif. Tissue Int. | pmid:20811796 |
| Josson S et al. | Tumor-stroma co-evolution in prostate cancer progression and metastasis. | 2010 | Semin. Cell Dev. Biol. | pmid:19948237 |
| Luvizuto ER et al. | Histomorphometric analysis and immunolocalization of RANKL and OPG during the alveolar healing process in female ovariectomized rats treated with oestrogen or raloxifene. | 2010 | Arch. Oral Biol. | pmid:19948337 |
| Ozçaka O et al. | Plasma osteoprotegerin levels are decreased in smoker chronic periodontitis patients. | 2010 | Aust Dent J | pmid:21133939 |
| Xu M et al. | Basal bone phenotype and increased anabolic responses to intermittent parathyroid hormone in healthy male COX-2 knockout mice. | 2010 | Bone | pmid:20471507 |
| Oelzner P et al. | Combination therapy with dexamethasone and osteoprotegerin protects against arthritis-induced bone alterations in antigen-induced arthritis of the rat. | 2010 | Inflamm. Res. | pmid:20306217 |
| Yue H et al. | Role of nuclear unphosphorylated STAT3 in angiotensin II type 1 receptor-induced cardiac hypertrophy. | 2010 | Cardiovasc. Res. | pmid:19696070 |
| Jang JJ et al. | Elevated osteoprotegerin is associated with abnormal ankle brachial indices in patients infected with HIV: a cross-sectional study. | 2010 | J Int AIDS Soc | pmid:20307322 |
| Jørgensen L et al. | Bone loss in relation to serum levels of osteoprotegerin and nuclear factor-kappaB ligand: the Tromsø Study. | 2010 | Osteoporos Int | pmid:19701599 |
| Hope S et al. | Osteoprotegerin levels in patients with severe mental disorders. | 2010 | J Psychiatry Neurosci | pmid:20569643 |
| Molines L et al. | Charcot's foot: newest findings on its pathophysiology, diagnosis and treatment. | 2010 | Diabetes Metab. | pmid:20570543 |
| Mysliwiec J et al. | Role of interleukin-6 on RANKL-RANK/osteoprotegerin system in hypothyroid ovariectomized mice. | 2010 | Folia Histochem. Cytobiol. | pmid:21478097 |
| Baekken M et al. | Osteoprotegrin and soluble tumor necrosis factor receptor 1 are associated with microalbuminuria in nontreated HIV-infected patients. | 2010 | J. Acquir. Immune Defic. Syndr. | pmid:20190590 |
| Tong PJ et al. | [In vitro induction studies of YouGui drink on culture of steroid induced necrosis of femoral head rat osteoblast]. | 2010 | Zhongguo Gu Shang | pmid:20191959 |
| Costa PP et al. | Salivary interleukin-6, matrix metalloproteinase-8, and osteoprotegerin in patients with periodontitis and diabetes. | 2010 | J. Periodontol. | pmid:20192865 |
| Takahashi N et al. | [Osteoprotegerin (OPG)]. | 2010 | Nippon Rinsho | pmid:20960766 |
| Yan MZ et al. | Raloxifene inhibits bone loss and improves bone strength through an Opg-independent mechanism. | 2010 | Endocrine | pmid:20963556 |
| Ambrus C et al. | Bone mineral density in patients on maintenance dialysis. | 2010 | Int Urol Nephrol | pmid:20039127 |
| Jensen ED et al. | Bone morphogenic protein 2 directly enhances differentiation of murine osteoclast precursors. | 2010 | J. Cell. Biochem. | pmid:20039313 |
| Li XD et al. | Panax notoginseng saponins potentiate osteogenesis of bone marrow stromal cells by modulating gap junction intercellular communication activities. | 2010 | Cell. Physiol. Biochem. | pmid:21220939 |
| Tokuyama N and Tanaka S | [Cytokines in bone diseases. Genetic disorders of RANKL-RANK-OPG system]. | 2010 | Clin Calcium | pmid:20890036 |
| Hosogane N and Miyamoto T | [Cytokines in bone diseases. Osteoprotegerin and juvenile Paget's disease]. | 2010 | Clin Calcium | pmid:20890037 |